Senior Director, Clinical Finance

Millbrae, California, United States

Apply with AI Apply

Not SpecifiedCompensation

Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Biopharmaceutical, Pharmaceutical, HealthcareIndustries

Requirements

Candidates should possess 15+ years of experience with a Bachelor’s degree in financial planning & analysis, or 12+ years with a post graduate degree, demonstrating a strong focus on clinical finance within the biopharmaceutical, pharmaceutical, or healthcare industries. They should excel at navigating complex financial landscapes, translating data into actionable insights, and optimizing processes to support business growth, and thrive in fast-paced, high-growth environments.

Responsibilities

The Senior Director, Clinical Finance will develop and execute financial strategies aligned with Eikon’s clinical program objectives, lead clinical financial planning processes including budgeting and forecasting, oversee clinical trial financial operations and site payments, manage financial oversight of multiple global clinical trials, create and maintain robust financial models, provide strategic financial insights to senior leadership, ensure compliance with financial regulations, identify process improvements, and support strategic initiatives such as mergers and acquisitions. They will also lead, mentor, and develop a high-performing finance team, fostering a culture of excellence.

Skills

Clinical Finance

Financial Strategy

Financial Planning & Analysis (FP&A)

Accounting

Payments

Budgeting

Forecasting

Financial Modeling

Biopharmaceutical Finance

Pharmaceutical Finance

Healthcare Finance

Eikon Therapeutics

Biotech startup developing innovative medicines

About Eikon Therapeutics

Eikon Therapeutics focuses on discovering and developing new medicines in the pharmaceutical industry. The company employs advanced technologies to study biological systems, aiming to identify new drug targets by examining the dynamic aspects of biology rather than just static chemical processes. Their team consists of diverse professionals, including data scientists, chemists, and engineers, which allows them to combine science and engineering to create new therapies that aim to improve and extend life. A key feature of Eikon's approach is their proprietary single-molecule tracking (SMT) platform, which enables rapid visualization of protein movements in living cells. This technology, along with artificial intelligence and automation, allows for precise inventorying of molecular interactions. Eikon Therapeutics targets patients with serious diseases who need effective treatments, generating revenue through the development and commercialization of their therapies.

Hayward, CaliforniaHeadquarters

2019Year Founded

$750.8MTotal Funding

SERIES_CCompany Stage

AI & Machine Learning, BiotechnologyIndustries

201-500Employees